The convergence of seemingly disparate realms – male performance medications, volatile copyright, and the intoxicating allure of gambling – presents a fascinating, if occasionally unpredictable, scenario for a certain demographic of investors. Some are drawn to the perceived “opportunity” that combining these areas might provide; perhaps a